StockNews.com Begins Coverage on SenesTech (NASDAQ:SNES)

StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES) in a research note released on Friday morning. The firm issued a sell rating on the stock.

Separately, HC Wainwright boosted their price target on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research note on Thursday, December 12th.

SenesTech Price Performance

Shares of NASDAQ SNES opened at $1.66 on Friday. The company has a market capitalization of $2.90 million, a PE ratio of -0.17 and a beta of -0.03. The company has a quick ratio of 4.92, a current ratio of 6.32 and a debt-to-equity ratio of 0.05. SenesTech has a twelve month low of $1.30 and a twelve month high of $9.80. The firm has a fifty day simple moving average of $2.49 and a 200 day simple moving average of $2.68.

SenesTech (NASDAQ:SNES) last posted its quarterly earnings data on Wednesday, March 12th. The company reported ($1.22) earnings per share for the quarter, topping the consensus estimate of ($1.50) by $0.28. The firm had revenue of $0.50 million during the quarter, compared to analyst estimates of $0.71 million. SenesTech had a negative return on equity of 150.33% and a negative net margin of 403.51%. On average, sell-side analysts forecast that SenesTech will post -10.22 EPS for the current year.

SenesTech Company Profile

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.